Smartphone-connected implantable cardioverter-defibrillators and pacemakers are one of the top ten medical innovations of the past few months that will improve healing and change healthcare for years to come, according to the Cleveland Clinic (CC).
This new advance in telemedicine increases the connection between patients and their treatment, according to this centennial healthcare complex and reference medical center in the United States, located in Ohio and which includes both hospital care and clinical research.
Every year a distinguished staff of CC physicians and researchers (https://my.clevelandclinic.org) selects the most innovative medical technologies, therapies and drugs. Cardiology connectivity has been one of the highlights in 2021.
Although millions of patients have pacemakers and defibrillators surgically implanted in their bodies to keep them alive, monitoring of these devices is a crucial issue and has so far been one-sided, according to CC.
It points out that now a pacemaker enabled to use the Bluetooth wireless system and used together with a mobile application (‘app’), allows patients to transmit their cardiological data remotely, using their mobile phone or electronic tablet, without additional monitoring devices and thus increasing patients’ commitment to their heart health.
LAST GENERATION CARDIAC TELEMEDICINE.
Through this ‘app’, for the first time patients with pacemakers can safely and quickly access and transmit data on their cardiology history, the battery life of the implanted device, the monitoring of their vital signs and their physical activity .
Implantable devices such as pacemakers and defibrillators send electrical impulses to the chambers of the heart muscle to contract and pump blood through the body. They are used to prevent or correct arrhythmias, irregular heartbeat, too slow or too fast, explained from CC.
He adds that remote monitoring (at a distance) of these devices is essential. It typically requires patients to connect to a monitor or console at home, usually located next to their bed, to transmit data to their doctor or clinic, according to CC.
Although millions of patients wear these devices on their bodies, many lack a basic knowledge of the device and how it works, which results in adherence to remote monitoring being below what is desirable, according to this medical center.
Bluetooth-connected pacemakers used in conjunction with a mobile app can solve these problems by enabling patients to better understand the data on their device and transmit that information to their physicians.
The American firm Medtronic (www.medtronic.com) based in Fridley (Minnesota, USA) is a leader in the development and manufacture of this type of device.
“We are one of the few to offer a wide variety of smartphone-compatible implanted heart devices,” explains Dr. Rob Kowal, vice president of medical affairs and chief medical officer in the Heart Rate and Heart Failure (CRHF) business at Medtronic.
According to Dr. Kowal, “there is growing evidence that connectivity between heart devices and the ‘smartphone’ can save lives.”
“We know of a patient who felt dizzy while mowing the lawn with his phone in his pocket. When he sat in his living room to rest, he received a call from his clinic. His implanted device had alerted his medical providers to a problem and they made immediate plans to correct it, ”he says.
CONNECTIVITY, VERY VALUABLE.
“With the traditional monitoring system, that information would have required the patient to be close to his bedside monitor, which would likely have delayed his medical care and attention,” according to Kowal.
A recent study shows that patients using the smartphone-based ‘app’ for heart devices, MyCareLink Heart, are more likely to comply with their data transmission schedule than if they use ‘bedside’ bedside monitors.
That research shows that patients who follow their data transmission program may have higher survival rates, fewer emergency room visits and shorter hospital stays, according to Medtronic.
“This type of technology is the future,” says Dr. Khaldoun G. Tarakji, director of the Center for Digital Health at the Heart, Vascular and Thoracic Institute at the Cleveland Clinic.
Tarakji led the ‘BlueSync Field Assessment Study’, which analyzed the performance of the MyCareLink Heart platform and in that study evaluated a ntrica. It provides energy to the national electricity grid and water for aqueducts and crops. But apart from its value as an energy and water resource, the lake of this dam has become an important fishing area for subsistence; the presence of fishermen living near the area is common; and other residents in various parts of the province used to imitate a young Glaucus, before becoming a Triton, and use the fruit of these waters to pay for their subsistence expenses.
Tilapia abound in this lake along with other freshwater species, highly appreciated by end consumers. The Government ordered the release of 200,000 fingerlings in this lake, to encourage the production of freshwater fish. There is an entity that organizes fishermen, called La Ciénaga Agropesca Association (Asoapelac), which has taken some institutional steps to make activity in the area important.